novo nordisk's wegovy reduces cardiovascular risk more than lilly's tirzepatide Weight-loss drugs becoming better value for money, says watchdog Novo Nordisk cuts profit outlook

10.1038/mtm.2014.48 106 SreedharA.Aguilera-AguirreL.SinghK

Available from: ScienceDirect Tang B, et al

Over-the-counter supplements for joint health, such as glucosamine and chondroitin, have been subject to skepticism over the years

This novel view on GLP-1 mechanisms has recently been highlighted by Ludwig and Holst [32]

Two patients may have identical BMI scores but very different waist measurements and health risks

The peptide's upregulation of VEGFR2 at both mRNA and protein levels sensitizes healing tissues to angiogenic signals while its activation of the Src-Caveolin-1-eNOS pathway generates nitric oxide essential for vascular development and tissue perfusion